Expert Perspectives on the Rapid Expansion of Atopic Dermatitis Treatments
Raj Chovatiya, MD, PhD, and Neal Bhatia, MD, share their thoughts on the clinical implications of the rapid expansion of the atopic dermatitis treatment armamentarium.
Gaps in Management of AD SOC Patients
Drs Angela Lamb, Omar Noor, and Neal Bhatia share what they consider to be the biggest gaps in care for patients with SOC: patient/provider education, building trust, and appropriate diagnosis of AD.
AD Patient Case: FST III
Three dermatologists discuss the case of an 18-year-old patient with AD who is exploring nonsteroidal options to manage his disease.
Cost and Access to AD Treatments
Drs Noor and Bhatia have a conversation about cost and financial assistance from pharmaceutical companies.
AD Patient Case: FST V
Drs Bhatia and Lamb discuss the case of a 12-year-old child with asthma and how they would manage his disease.
AD Patient Case: FST I
Experts discuss the case of a 4-year-old girl with lighter skin and treatment options for a young child.
Setting Expectations About Treatments With Patients
Three experts emphasize the importance of setting expectations for AD treatment with patients.
Mechanism of Action and AD Treatment Selection in Patients With Skin of Color
Drs Noor and Lamb discuss mechanisms of action of biologics and JAK inhibitors and the importance of patient communication while selecting AD treatments.
Approaching Treatment Selection in AD
Drs Lamb, Noor, and Bhatia discuss their approach to selecting treatment in light of recent AD approvals.
Communication About Adverse Effects of Atopic Dermatitis Treatments
Drs Noor and Lamb highlight the importance of frank discussion of adverse effects of atopic dermatitis treatments with patients.
Building Trust With Patients With Atopic Dermatitis
Drs Bhatia, Lamb and Noor talk about the importance of building trust with patients and highlight topics to discuss with patients and parents.
Increasing Awareness of Advances in AD Management with Physicians and Patients
Dermatology experts discuss strategies to increase awareness of advances in AD in patients with SOC.
Overview of Atopic Dermatitis in Patients of Skin of Color
Drs. Neal Bhatia and Angela Lamb provide an overview of atopic dermatitis and its prevalence in patients with skin of color (SOC).
JAK Inhibitors: Non-Responders and Safety Considerations
Drs James Q. Del Rosso and Neal Bhatia explain how to manage patients who fail therapy and provide safety considerations when treating those patients.
Oral JAK Inhibitors for Atopic Dermatitis
Experts discuss newly approved oral JAK inhibitors for the treatment of atopic dermatitis.
Topical JAK Inhibitors for Atopic Dermatitis
A review of topical JAK inhibitor ruxolitinib.
JAK Inhibitors: An Overview
James Q. Del Rosso, DO, and Neal Bhatia, MD, provide an overview of JAK inhibitors for the treatment of atopic dermatitis.
Photodynamic Therapy is an Effective, Long-Term Treatment for Actinic Keratosis
2024 Expert Insights: More Options than Ever
FDA Gives Go-Ahead on Quoin Pharmaceuticals’ QRX003 Netherton Syndrome Study
Improving Skin Radiance and Luminosity